StocksFundsScreenerSectorsWatchlists
XOMA

XOMA - XOMA Corp Stock Price, Fair Value and News

24.05USD+0.71 (+3.04%)Market Closed

Market Summary

XOMA
USD24.05+0.71
Market Closed
3.04%

XOMA Stock Price

View Fullscreen

XOMA RSI Chart

XOMA Valuation

Market Cap

279.6M

Price/Earnings (Trailing)

-6.85

Price/Sales (Trailing)

58.76

EV/EBITDA

-8.6

Price/Free Cashflow

-15.4

XOMA Price/Sales (Trailing)

XOMA Profitability

Operating Margin

97.30%

EBT Margin

-359.39%

Return on Equity

-46.02%

Return on Assets

-17.43%

Free Cashflow Yield

-6.49%

XOMA Fundamentals

XOMA Revenue

Revenue (TTM)

4.8M

Rev. Growth (Yr)

23.35%

Rev. Growth (Qtr)

120.84%

XOMA Earnings

Earnings (TTM)

-40.8M

Earnings Growth (Yr)

-236.5%

Earnings Growth (Qtr)

-265.02%

Breaking Down XOMA Revenue

Last 7 days

-5.8%

Last 30 days

7.2%

Last 90 days

34.8%

Trailing 12 Months

21.6%

How does XOMA drawdown profile look like?

XOMA Financial Health

Current Ratio

8.68

Debt/Equity

0.13

Debt/Cashflow

-1.56

XOMA Investor Care

Shares Dilution (1Y)

1.44%

Diluted EPS (TTM)

-4.04

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20233.4M4.0M4.4M4.8M
202240.9M41.0M40.5M6.0M
202131.6M33.8M36.0M38.2M
202011.0M10.5M2.2M29.4M
201913.0M11.7M19.6M18.4M
201840.8M29.0M17.1M5.3M
201717.3M29.1M40.9M52.7M
201656.8M54.7M53.2M5.6M
201518.1M14.7M11.6M55.4M
201429.4M28.2M27.1M18.9M
201333.4M31.2M30.3M35.5M
201252.5M45.2M36.2M33.8M
201143.3M52.6M57.9M58.2M
201082.2M66.0M49.8M33.6M
200900098.4M

Tracking the Latest Insider Buys and Sells of XOMA Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Oct 03, 2023
sitko bradley
bought
3,472
13.89
250
chief investment officer
Oct 02, 2023
sitko bradley
bought
21,375
14.25
1,500
chief investment officer
Oct 02, 2023
hughes owen
bought
13,830
13.83
1,000
exec chairman and interim ceo
Sep 26, 2023
hughes owen
bought
36,060
14.43
2,499
exec chairman and interim ceo
Sep 25, 2023
hughes owen
bought
14.65
14.65
1.00
exec chairman and interim ceo
May 31, 2023
sitko bradley
bought
25,700
17.1333
1,500
chief investment officer
May 24, 2023
hughes owen
bought
24,551
23.79
1,032
interim ceo
May 23, 2023
sitko bradley
bought
16,150
19.00
850
chief investment officer
May 23, 2023
hughes owen
bought
22,706
23.4569
968
interim ceo
May 19, 2023
sitko bradley
bought
19,500
19.5
1,000
chief investment officer

1–10 of 50

Which funds bought or sold XOMA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
new
-
38.00
38.00
-%
Mar 11, 2024
VANGUARD GROUP INC
added
1.65
1,955,090
7,797,270
-%
Feb 29, 2024
Scarborough Advisors, LLC
new
-
3,238
3,238
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.41
15,815
67,229
-%
Feb 15, 2024
BARCLAYS PLC
added
638
168,000
187,000
-%
Feb 15, 2024
Legal & General Group Plc
unchanged
-
3,118
13,080
-%
Feb 14, 2024
Metropolitan Life Insurance Co/NY
sold off
-100
-6,312
-
-%
Feb 14, 2024
Ameritas Investment Partners, Inc.
unchanged
-
2,664
11,174
-%
Feb 14, 2024
STATE STREET CORP
added
1.63
576,745
2,301,830
-%
Feb 14, 2024
DEUTSCHE BANK AG\
new
-
88,948
88,948
-%

1–10 of 47

Are Funds Buying or Selling XOMA?

Are funds buying XOMA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own XOMA
No. of Funds

Unveiling XOMA Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 16, 2024
biotechnology value fund l p
15.6%
1,789,844
SC 13D/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 14, 2022
eagle point credit management llc
0.0%
0
SC 13G/A
Feb 09, 2022
fmr llc
-
0
SC 13G
Apr 19, 2021
eagle point credit management llc
6.3%
149,248
SC 13G
Apr 02, 2021
biotechnology value fund l p
15.6%
1,760,384
SC 13D/A
Dec 15, 2020
biotechnology value fund l p
18.5%
2,040,124
SC 13D/A
Oct 09, 2020
biotechnology value fund l p
18.5%
2,040,124
SC 13D/A
Sep 23, 2020
biotechnology value fund l p
18.5%
2,040,124
SC 13D/A

Recent SEC filings of XOMA Corp

View All Filings
Date Filed Form Type Document
Mar 19, 2024
SC TO-T/A
SC TO-T/A
Mar 08, 2024
S-3
S-3
Mar 08, 2024
8-K
Current Report
Mar 08, 2024
10-K
Annual Report
Mar 08, 2024
S-4
Mergers and Acquisition
Mar 04, 2024
SC TO-T
SC TO-T
Feb 27, 2024
SC TO-C
SC TO-C
Feb 16, 2024
8-K
Current Report
Feb 09, 2024
SC 13G/A
Major Ownership Report
Jan 16, 2024
SC 13D/A
13D - Major Acquisition

Peers (Alternatives to XOMA Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
40.7B
6.8B
19.31% -24.90%
-8.64
5.95
-64.45% -156.37%
22.4B
152.6K
-0.77% 465779.94%
-2.4K
146.8K
- -9.98%
18.8B
1.8B
-0.33% -18.28%
-42.76
10.3
76.23% 61.08%
16.5B
2.4B
-4.10% -7.32%
98.3
6.81
15.42% 18.43%
12.8B
3.7B
-1.69% -18.94%
21.4
3.46
8.87% 75.42%
MID-CAP
7.1B
396.6M
-19.47% -8.81%
-13.41
17.87
425.83% 18.94%
5.4B
-
-20.51% 118.30%
-8.32
60.35
54.84% -34.79%
3.8B
270.6M
-13.09% 29.37%
-15.8
13.97
440.80% -27.84%
3.5B
240.7M
-7.70% 7.49%
-11.94
14.72
-1.03% -92.09%
3.0B
726.4M
-28.51% -9.28%
-49.71
4.19
40.45% 71.62%
SMALL-CAP
1.9B
398.2M
12.36% 9.77%
26.31
4.72
85.90% -14.05%
669.0M
983.7M
12.98% -18.87%
-1.23
0.68
-50.36% 17.16%
411.7M
881.7K
51.26% 463.55%
-9.23
466.16
-77.61% -5.33%
324.4M
4.9M
46.53% -11.16%
-2.4
66.66
-54.97% 51.72%
14.1M
2.1M
-13.49% -43.81%
-0.52
2.14
-13.45% 66.37%

XOMA Corp News

Latest updates
MarketBeat24 Mar 202403:47 am
Defense World22 Mar 202407:37 am
Yahoo Finance21 Mar 202411:30 am
Quartz08 Mar 202412:52 pm
Seeking Alpha16 Feb 202408:00 am

XOMA Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In null)
Income Statement (Quarterly)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue120.8%1,8338301,6584371,4864519833,10735,94594090114,24127,5805564448044228,8559628,1311,685
Operating Expenses229.0%21,7676,6177,61510,6077,6964,8235,7505,1725,5804,2853,9656,8023,7083,2463,5956,4204,4235,9645,6736,1954,564
  S&GA Expenses14.1%7,2656,3685,7776,1967,5714,7945,7105,1165,5384,2553,9276,7413,6733,2123,5576,3584,2935,8214,9495,9394,327
  R&D Expenses0%25.0025.0039.0054.0028.0029.0040.0056.0042.0030.0038.0061.0036.0034.0038.0062.00130143724256237
EBITDA Margin7.3%-3.50*-3.77*-4.12*-4.95*-2.76*0.40*0.40*0.40*0.43*0.26*0.39*0.39*---------
Interest Expenses-----------172289360434508542583484423429365
Income Taxes------110--95.0091.00---25.00-26.00-1,526-----98.00
Earnings Before Taxes---------29,935-4,436-2,237-7,37322,691-1,077-3,533-6,284-4,3213,178-4,0723,233-3,110
EBT Margin7.3%-3.59*-3.88*-4.24*-5.09*-2.84*0.39*0.39*0.39*0.42*0.24*0.36*0.34*---------
Net Income-265.0%-20,109-5,509-5,400-9,813-5,976-4,178-4,670-2,28029,844-4,436-2,237-7,37322,666-1,077-3,533-4,758-4,3213,178-4,0723,233-3,012
Net Income Margin-41.8%-8.58*-6.05*-6.29*-7.34*-2.84*0.46*0.45*0.51*0.41*0.24*0.35*0.34*---------
Free Cashflow-87.1%-3,927-2,099-7,208-4,924-3,890-3,663-4,317-1,00930,642-3,075-3,975-914---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets88.8%23412412613414014615415916713113612012586.0088.0092.0096.0086.0078.0076.0064.00
  Current Assets390.7%16935.0038.0045.0061.0080.0087.0090.0097.0075.0087.0070.0088.0048.0052.0056.0060.0044.0046.0051.0048.00
    Cash Equivalents376.7%16033.0031.0044.0058.0078.0083.0089.0095.0072.0084.0070.0086.0046.0049.0053.0057.0040.0042.0048.0046.00
  Net PPE400.0%0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Liabilities703.0%14618.0016.0019.0016.0016.0019.0019.0025.0019.0019.0038.0039.0048.0049.0051.0052.0060.0057.0052.0045.00
  Current Liabilities88.7%19.0010.007.0010.007.005.008.008.0013.007.006.0013.0012.0012.0011.0010.009.0010.0012.007.006.00
  Long Term Debt------------12.0013.0021.0023.0025.0027.0029.0023.0021.0022.00
    LT Debt, Current------------7.008.009.008.006.005.004.003.002.001.00
    LT Debt, Non Current------------12.0013.0021.0023.0025.0027.0029.0023.0021.0022.00
Shareholder's Equity-16.3%89.0010611011512413013514014211211782.0086.0038.0038.0041.0044.0026.0021.0024.0019.00
  Retained Earnings-1.7%-1,223-1,203-1,197-1,192-1,182-1,176-1,172-1,167-1,165-1,195-1,190-1,188-1,181-1,203-1,202-1,199-1,194-1,190-1,193-1,189-1,192
  Additional Paid-In Capital0.2%1,3121,3091,3081,3071,3061,3071,3071,3071,3071,3071,3071,2701,2671,2421,2411,2401,2381,2161,2141,2131,211
Accumulated Depreciation---------------------0.00
Shares Outstanding0.2%11.0011.0011.0011.0011.0011.0011.0011.0011.0011.0011.0011.00---------
Float-------155---240---137---94.00--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-87.1%-3,927-2,099-7,208-4,924-3,890-3,663-4,317-1,00930,642-3,075-3,975-91417,678-2,436-2,870-2,280-4,1483,799-3,0933,157-2,712
  Share Based Compensation-2.5%2,6492,7172,1631,5709888058379781,7507797682,8986927087731,7881,69050056.001,7281,622
Cashflow From Investing0.3%5,5115,494-4,482-7,234-15,24726.00--5,000-6,000-7,000--13,500-200-----13,000-6,000-300-
Cashflow From Financing9200.4%124,494-1,368-1,165-1,368-1,322-1,260-1,134-735-1,439-1,53617,810-2,00023,161-1,321-951-1,09621,0926,6182,984-20120,059
  Dividend Payments0%1,3681,3681,3681,3681,3681,3681,3681,368-------------

XOMA Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:  
Revenue from contracts with customers$ 2,650$ 4,150
Revenue recognized under units-of-revenue method2,1081,877
Total revenues4,7586,027
Operating expenses:  
Research and development143153
General and administrative25,60623,191
Impairment charges (Note 4, Note 5)15,828 
Arbitration settlement costs (Note 3)4,132 
Amortization of intangible assets89797
Total operating expenses46,60623,441
Loss from operations(41,848)(17,414)
Other income (expense):  
Interest expense(569) 
Other income (expense), net1,586295
Loss before income tax(40,831)(17,119)
Income tax benefit015
Net loss(40,831)(17,104)
Comprehensive loss(40,831)(17,104)
Net loss attributable to common stockholders, basic(46,303)(22,576)
Net loss attributable to common stockholders, diluted$ (46,303)$ (22,576)
Basic net loss per share attributable to common stockholders (in dollars per share)$ (4.04)$ (1.98)
Diluted net loss per share attributable to common stockholders (in dollars per share)$ (4.04)$ (1.98)
Weighted average shares used in computing basic net loss per share attributable to common stockholders (in shares)11,47111,413
Weighted average shares used in computing diluted net loss per share attributable to common stockholders (in shares)11,47111,413

XOMA Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 153,290,000$ 57,826,000
Short-term restricted cash160,000 
Short-term equity securities161,000335,000
Trade and other receivables, net1,004,0001,000
Short-term royalty and commercial payment receivables14,215,0002,366,000
Prepaid expenses and other current assets483,000725,000
Total current assets169,313,00061,253,000
Long-term restricted cash6,100,000 
Property and equipment, net25,0007,000
Operating lease right-of-use assets378,00029,000
Long-term royalty and commercial payment receivables57,952,00063,683,000
Intangible assets, net 15,150,000
Other assets - long term533,000260,000
Total assets234,301,000140,382,000
Current liabilities:  
Accounts payable653,000524,000
Accrued and other liabilities2,768,0002,918,000
Contingent consideration under RPAs, AAAs and CPPAs7,000,00075,000
Operating lease liabilities54,00034,000
Unearned revenue recognized under units-of-revenue method2,113,0001,899,000
Preferred stock dividend accrual1,368,0001,368,000
Current portion of long-term debt5,543,000 
Total current liabilities19,499,0006,818,000
Unearned revenue recognized under units-of-revenue method - long-term7,228,0009,550,000
Long-term operating lease liabilities335,000 
Long-term debt118,518,000 
Total liabilities145,580,00016,368,000
Commitments and Contingencies (Note 13)
Stockholders' equity:  
Common stock, $0.0075 par value, 277,333,332 shares authorized, 11,495,492 and 11,454,025 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively86,00086,000
Additional paid-in capital1,311,809,0001,306,271,000
Accumulated deficit(1,223,223,000)(1,182,392,000)
Total stockholders' equity88,721,000124,014,000
Total liabilities and stockholders' equity234,301,000140,382,000
8.625% Series A Cumulative, Perpetual Preferred Stock  
Stockholders' equity:  
Preferred Stock49,00049,000
8.375% Series B Cumulative, Perpetual Preferred Stock  
Stockholders' equity:  
Preferred Stock
Convertible preferred stock  
Stockholders' equity:  
Preferred Stock
XOMA
XOMA Corporation operates as a biotech royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with various assets. The company was incorporated in 1981 and is headquartered in Emeryville, California.
 CEO
 WEBSITEwww.xoma.com
 EMPLOYEES11

XOMA Corp Frequently Asked Questions


What is the ticker symbol for XOMA Corp? What does XOMA stand for in stocks?

XOMA is the stock ticker symbol of XOMA Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of XOMA Corp (XOMA)?

As of Wed Mar 27 2024, market cap of XOMA Corp is 271.35 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XOMA stock?

You can check XOMA's fair value in chart for subscribers.

What is the fair value of XOMA stock?

You can check XOMA's fair value in chart for subscribers. The fair value of XOMA Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of XOMA Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for XOMA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is XOMA Corp a good stock to buy?

The fair value guage provides a quick view whether XOMA is over valued or under valued. Whether XOMA Corp is cheap or expensive depends on the assumptions which impact XOMA Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XOMA.

What is XOMA Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, XOMA's PE ratio (Price to Earnings) is -6.65 and Price to Sales (PS) ratio is 57.03. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XOMA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on XOMA Corp's stock?

In the past 10 years, XOMA Corp has provided -0.147 (multiply by 100 for percentage) rate of return.